title: Lessons from the bedside: ketoacidosis and SGLT2 inhibitors.
authors: Alfred Hospital, Melbourne, VIC yvonneytchow@gmail.com.
authors: Yvonne Y
authors: YY
authors: Chow
authors: Alfred Hospital, Melbourne, VIC.
authors: Roisin
authors: R
authors: Worsley
authors: Alfred Hospital, Melbourne, VIC.
authors: Duncan J
authors: DJ
authors: Topliss
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D000077203:Sodium-Glucose Transporter 2 Inhibitors